{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:20:32Z","timestamp":1783624832953,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejim.2025.01.012","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T12:27:33Z","timestamp":1737203253000},"page":"35-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Aspirin-free strategies after percutaneous coronary intervention: Old habits, consolidated evidence and future perspectives"],"prefix":"10.1016","volume":"133","author":[{"given":"Antonio","family":"Landi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-2995","authenticated-orcid":false,"given":"Stefano","family":"De Servi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-1272","authenticated-orcid":false,"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ejim.2025.01.012_bib0001","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/heartjnl-2022-321603","article-title":"Antithrombotic therapy in patients with established atherosclerotic coronary disease","volume":"109","author":"Landi","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2025.01.012_bib0002","first-page":"ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.01.012_bib0003","first-page":"ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ejim.2025.01.012_bib0004","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/CIRCULATIONAHA.124.069012","article-title":"Demystifying the contemporary role of 12-month dual antiplatelet therapy after acute coronary syndrome","volume":"150","author":"Valgimigli","year":"2024","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ejim.2025.01.012_bib0005","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.cjca.2022.06.014","article-title":"Radial versus femoral access in ACS patients undergoing complex PCI is associated with consistent bleeding benefit and no excess of risks","volume":"38","author":"Landi","year":"2022","journal-title":"Can J Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2025.01.012_bib0006","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/ehjacc\/zuab090","article-title":"Ischemic and bleeding risk in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: is it time to REACT?","volume":"10","author":"Valgimigli","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"10456","key":"10.1016\/j.ejim.2025.01.012_bib0007","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(24)01616-7","article-title":"De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials","volume":"404","author":"Valgimigli","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2025.01.012_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2024.0133","article-title":"Ticagrelor or clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level meta-analysis","author":"Valgimigli","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejim.2025.01.012_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.123.066720","article-title":"An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial","author":"Natsuaki","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejim.2025.01.012_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2023.04.051","article-title":"P2Y12 inhibitor or aspirin monotherapy for secondary prevention of coronary events","volume":"82","author":"Gragnano","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ejim.2025.01.012_bib0011","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/CIRCULATIONAHA.123.064473","article-title":"Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the academic research consortium","volume":"147","author":"Capodanno","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ejim.2025.01.012_bib0012","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jcin.2023.01.366","article-title":"Abbreviated or standard antiplatelet therapy in HBR patients","volume":"16","author":"Landi","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"9678","key":"10.1016\/j.ejim.2025.01.012_bib0013","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejim.2025.01.012_bib0014","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/CIRCULATIONAHA.122.062770","article-title":"Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM Extended Study","volume":"147","author":"Kang","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.01.012_bib0015","first-page":"ehae617","article-title":"Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial","author":"Watanabe","year":"2024","journal-title":"Eur Heart J"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525000226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525000226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T14:21:32Z","timestamp":1740925292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525000226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":15,"alternative-id":["S0953620525000226"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.01.012","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin-free strategies after percutaneous coronary intervention: Old habits, consolidated evidence and future perspectives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}